Loading...
Challenges in Combining Antiangiogenic Therapy With Transarterial Chemoembolization for Hepatocellular Carcinoma
BACKGROUND: The combination of systemic antiangiogenic therapy and transarterial chemoembolization (TACE) for the treatment of unresectable hepatocellular carcinoma (HCC) is the subject of several ongoing clinical trials. We present a series of patients treated with sorafenib and TACE at our institu...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International Society of Gastrointestinal Oncology
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171975/ https://ncbi.nlm.nih.gov/pubmed/25276263 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|